Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2026-02-03 @ 5:11 AM
Study NCT ID:
NCT04870606
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2021-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness
Sponsor:
Suzhou Kintor Pharmaceutical Inc,
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Efficacy and Safety | View |
Keywords: